Dawn Adams

Dawn Adams

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2025 in Cognitive and Behavioral Practice
Verified
Journal Article
Open access
MHMadison A. Hooper
Madison A. Hooper
HZHana Zickgraf
Hana Zickgraf
KRKatrina Rbeiz
Katrina Rbeiz
JPJoanna Perl
Joanna Perl
DADawn Adams
Dawn Adams

14 April 2025 in Current Gastroenterology Reports
Verified
Journal Article
Open access
PDF file
KMKaitlyn Mi
Kaitlyn Mi
SCScarlett Cao
Scarlett Cao
DADawn Adams
Dawn Adams
Purpose of Review: Non-celiac enteropathies (NCE) can be due to a variety of causes. The workup for NCE includes history, physical, laboratory and histology review and can be difficult. Enteropathies can result in serious illness due to consequences of malabsorption including severe weight loss, nutritional deficiencies, and debilitating diarrhea. Recognition and support of these consequences while investigating underlying etiology is essential. Recent Findings: Recent studies in NCEs have focused on improving diagnostic accuracy and predicting long-term outcomes in patients with NCEs. Further, literature has emphasized the importance of histological analysis, with a focus on differentiating between various enteropathies that cause villous atrophy, highlighting the complexity and need for personalized approaches in managing these conditions. Summary: Identification of etiologies of NCEs requires review of patients’ detailed history, medications, and lab results. Common etiologies include immunodeficiencies, infectious, iatrogenic, and malignant causes. Using a systematic approach can lead to proper diagnosis and tailor treatment choices, benefiting patient outcomes. Supportive nutrition care should be initiated early when applicable to minimize morbidity.

27 February 2021 in Digestive Diseases and Sciences
Verified
Journal Article
Open access
PDF file
MBMiles Basil
Miles Basil
DSDavid Schwartz
David Schwartz
RDRobin Dalal
Robin Dalal
SHSara Horst
Sara Horst
ESElizabeth Scoville
Elizabeth Scoville
YCYash Choksi
Yash Choksi
Background While the pathogenesis of inflammatory bowel disease (IBD) is incompletely understood, disruption of epithelial integrity is suspected to play a prominent role in disease initiation and progression. Currently, there is no convenient way to measure this in vivo. Aims Our aim is to determine whether a mucosal integrity (MI) testing device that has been used to measure MI in the esophagus can also be used to measure barrier function in the colon during colonoscopy. Methods Mucosal integrity testing was measured in patients with IBD (n = 17) and controls (n = 7) during colonoscopy. During the procedure, an MI catheter was passed down the working channel of the colonoscope and placed along the mucosal wall to measure MI in the rectum, left, transverse, and right colon. In patients with IBD, MI measurements and biopsies were taken in areas which appeared inflamed when present. We then determined if there was a significant difference in MI between patients with IBD and controls. Results MI was significantly higher in the rectum of patients with IBD (CD and UC combined) versus control colons [767 (618–991) vs. 531 (418–604) ohms, P < 0.01]. There were no significant differences in MI among patients with IBD versus controls in the right, transverse, or left colon. Within the IBD group, there were no significant differences in MI between inflamed versus non-inflamed rectums. There was no correlation between quality of life scores or endoscopic severity with MI, though this study was likely underpowered to detect these differences. Conclusion Rectal MI is significantly higher in patients with IBD versus controls. Future studies are needed to determine how this information can be used clinically.

1 June 2020 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
DADawn Adams
Dawn Adams
DPDhyanesh Patel
Dhyanesh Patel
LELauren Evers
Lauren Evers
JSJames C. Slaughter
James C. Slaughter
THTina Higginbotham
Tina Higginbotham
MVMichael Vaezi
Michael Vaezi

9 March 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
KRKatrina Rbeiz
Katrina Rbeiz
MHMadison A. Hooper
Madison A. Hooper
HZHana Zickgraf
Hana Zickgraf
ABAlyson Basil
Alyson Basil
JPJoanna Perl
Joanna Perl
DADawn Adams
Dawn Adams
Background/Objectives: Food insecurity (FI) is associated with adverse physical and mental health outcomes and poses unique challenges for individuals with celiac disease (CD), who must adhere to a lifelong, strict gluten-free diet (GFD) as their sole treatment. Gluten-free foods are often more expensive and less accessible, potentially exacerbating dietary burden and symptom severity. This study aimed to examine associations between food insecurity and gastrointestinal symptoms, dietary burden, disordered eating symptoms, and mental health outcomes in adults with CD. Methods: Participants were 397 adults with CD who completed a routine pre-visit screener at a tertiary celiac disease clinic in the southeastern United States. Food insecurity was assessed using the Hunger Vital Signs. Measures included gastrointestinal symptoms (GSRS), impact of following a gluten-free diet (IGFDQ), avoidant/restrictive eating (NIAS), eating disorder psychopathology (EDE-Q7), anxiety (GAD-2), and depression (PHQ-2). Group comparisons between food-secure and participants screening positive for food insecurity (high-risk of FI) were conducted using independent t-tests or Mann–Whitney U tests as appropriate. Missing data were handled using multiple imputations. Results: A total of 15.6% of participants were at high risk of FI. Compared to food-secure individuals, participants at high-risk of FI reported significantly greater gastrointestinal symptom severity, including bloating, constipation, diarrhea, and overall symptom burden. Participants at high risk of FI also reported significantly greater perceived burden of adhering to a gluten-free diet. Additionally, higher levels of avoidant/restrictive eating symptoms and shape/weight overvaluation were observed among high-risk FI individuals, though group differences in anxiety and depression symptoms were not statistically significant. Conclusions: FI is associated with greater gastrointestinal symptom burden and increased difficulty adhering to a gluten-free diet among adults with celiac disease. These findings highlight risk of FI as a clinically relevant barrier to effective disease management and underscore the importance of routine screening and targeted support for high-risk FI individuals with CD.

27 February 2025 in Gastrointestinal Endoscopy Clinics of North America
Verified
Journal Article
Closed access
DADawn Adams
Dawn Adams
ICIsabel Comino
Isabel Comino
BLBenjamin Lebwohl
Benjamin Lebwohl